• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


RxLightning Establishes New Albany, Indiana, Headquarters

RxLightning, a health technology startup, will locate its headquarters in New Albany, Indiana. The project is expected to create 175 jobs by the end of 2025.

The company will lease, renovate, and equip an historic, three-story building at 227 Pearl Street, later this year. RxLightning will invest in additional computers, hardware and software to support its growing team and its growing network of providers who utilize its platform.

“This is an incredibly exciting move for RxLightning,” said Julia Regan, co-founder and CEO of RxLightning. “Our new expanded headquarters will allow us to continue our growth and work collaboratively to accelerate the speed at which patients get access to medicine they need. The state of Indiana, the city of New Albany and One Southern Indiana have been amazing partners in this endeavor. We considered other locations, but we’re thrilled to remain here in southern Indiana.”

Pending approval from the Indiana Economic Development Corporation (IEDC) board of directors, the IEDC will commit an investment in RxLightning of up to $4 million in conditional tax credits based on the company’s creation plans. The tax credits are performance-based, meaning RxLightning is eligible to claim incentives once eligible employees are hired. The city of New Albany approved additional incentives to support training and workforce development.

“RxLightning is a perfect example of how Indiana innovators are advancing the industries of the future,” noted Indiana Secretary of Commerce Brad Chambers. “The company’s solutions, powered by skilled and hardworking Hoosiers, are helping patients access life-saving treatments. Indiana is a leader in medical devices and pharmaceuticals, and now we’re the ideal destination for growing health tech companies like RxLightning.”

RxLightning has grown significantly since its founding, raising $8.5 million in funding from investors around the world while growing its team by approximately 50% so far this year. The company’s platform streamlines the specialty drug enrollment process for both doctors and patients, reducing paperwork and cutting the enrollment time from weeks to hours. The digitized, single solution, which is free for providers and patients, supports more than 1,200 specialty medications, helping patients get access to the treatments they need even faster.

Exclusive Research